{"product_id":"aod-9604-peptide-intelligence-monograph-fime","title":"AOD-9604 Peptide Intelligence Monograph | FIME","description":"\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eGrowth Hormone Fragment • Adipose Metabolism • Weight-Loss Claims • Evidence Reality\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eAOD-9604 is widely promoted as a “fat-burning peptide.” But what does the human evidence actually show?\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThe \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eFounder’s Institute of Medicine \u0026amp; Education AOD-9604 Peptide Intelligence Monograph\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e provides an evidence-based examination of this growth-hormone-derived peptide—from its compelling biological rationale and preclinical research to the human obesity trials that ultimately challenged the original therapeutic hypothesis.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eInside this monograph:\u003c\/span\u003e\u003c\/h3\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eWhat AOD-9604 is and how it relates to human growth hormone\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eProposed effects on lipolysis, lipogenesis, and fat oxidation\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003ePreclinical metabolic and adiposity research\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eHuman obesity and weight-loss clinical trials\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eThe pivotal clinical-development findings\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eGH\/IGF-1 considerations\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eSafety and long-term evidence limitations\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eOral versus contemporary subcutaneous-use considerations\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eCompounding and product-quality concerns\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eFDA and regulatory context\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eEmerging musculoskeletal and regenerative research\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eFIME evidence grading and clinical interpretation\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3\u003e\u003cspan\u003eThe Key Distinction\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eAOD-9604 has biological plausibility and meaningful human research behind it—but \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003ebiological activity is not the same as demonstrated clinical efficacy\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThe larger human clinical-development program did not establish AOD-9604 as an effective weight-loss therapy.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003eThat distinction is exactly why this monograph exists.\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003e\u003cspan\u003eFIME Evidence Perspective\u003c\/span\u003e\u003c\/h3\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eMechanistic Plausibility:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Moderate\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003ePreclinical Evidence:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Moderate\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eHuman Exposure:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Moderate\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eHuman Weight-Loss Efficacy:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Low \/ Not Established\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eLong-Term Human Safety:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Low\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eEvidence for Contemporary Subcutaneous Use:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e Very Low\u003c\/span\u003e\u003cbr\u003e\u003cstrong\u003e\u003cspan\u003eFDA-Approved Therapeutic Indication:\u003c\/span\u003e\u003c\/strong\u003e\u003cspan\u003e None\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eEvidence over hype. Science over claims. Integrity over revenue.\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cstrong\u003e\u003cspan\u003eVersion 1.0 Final\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp class=\"isSelectedEnd\"\u003e\u003cspan\u003ePublished by the \u003c\/span\u003e\u003cstrong\u003e\u003cspan\u003eFounder’s Institute of Medicine \u0026amp; Education\u003c\/span\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cspan\u003eFor professional education, scientific review, and evidence-based discussion. Not individualized medical advice, a prescription, or a treatment protocol. AOD-9604 is not FDA-approved for obesity or weight loss.\u003c\/span\u003e\u003c\/em\u003e\u003c\/p\u003e","brand":"Founder's Institute of Medicine \u0026 Education","offers":[{"title":"Default Title","offer_id":45384739815606,"sku":null,"price":24.95,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0736\/0990\/4310\/files\/ChatGPTImageAug26_2026_09_39_07PM_e837a713-85fb-4571-951a-5a1c5a4043e5.png?v=1787809536","url":"https:\/\/foundersinstitutemed.org\/products\/aod-9604-peptide-intelligence-monograph-fime","provider":"Founder's Institute of Medicine \u0026 Education","version":"1.0","type":"link"}